These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 20183780)

  • 1. [A comparative study of the hepatic transit time (HTT) of different ultrasound contrast agents in patients with liver metastases and healthy controls].
    Haendl T; Strobel D; Neureiter D; Esser K; Frieser M; Hahn EG; Bernatik T
    Ultraschall Med; 2010 Dec; 31(6):582-8. PubMed ID: 20183780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hepatic transit time analysis using contrast-enhanced ultrasound with BR1: A prospective study comparing patients with liver metastases from colorectal cancer with healthy volunteers.
    Hohmann J; Müller C; Oldenburg A; Skrok J; Frericks BB; Wolf KJ; Albrecht T
    Ultrasound Med Biol; 2009 Sep; 35(9):1427-35. PubMed ID: 19540656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of focal liver lesions by means of assessment of hepatic transit time with contrast-enhanced US.
    Zhou X; Liu JB; Luo Y; Yan F; Peng Y; Lin L; Zhuang H
    Radiology; 2010 Aug; 256(2):648-55. PubMed ID: 20656845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intrahepatic transit time predicts liver fibrosis in patients with chronic hepatitis B: quantitative assessment with contrast-enhanced ultrasonography.
    Li N; Ding H; Fan P; Lin X; Xu C; Wang W; Xu Z; Wang J
    Ultrasound Med Biol; 2010 Jul; 36(7):1066-75. PubMed ID: 20620694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic transit time in benign liver lesions.
    Haendl T; Strobel D; Steinebrunner N; Frieser M; Hahn EG; Bernatik T
    Ultraschall Med; 2008 Apr; 29(2):184-9. PubMed ID: 18382965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic vein transit time of SonoVue: a comparative study with Levovist.
    Lim AK; Patel N; Eckersley RJ; Goldin RD; Thomas HC; Cosgrove DO; Taylor-Robinson SD; Blomley MJ
    Radiology; 2006 Jul; 240(1):130-5. PubMed ID: 16720867
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Characterization of focal liver lesions with contrast-enhanced low MI real time ultrasound and SonoVue].
    Hohmann J; Skrok J; Puls R; Albrecht T
    Rofo; 2003 Jun; 175(6):835-43. PubMed ID: 12811698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic features of real-time contrast-enhanced ultrasound in focal nodular hyperplasia of the liver.
    Piscaglia F; Venturi A; Mancini M; Giangregorio F; Vidili G; Magnolfi F; Mirarchi M; Fornari F; Bolondi L
    Ultraschall Med; 2010 Jun; 31(3):276-82. PubMed ID: 19941252
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged heterogeneous liver enhancement on contrast-enhanced ultrasound.
    Cui XW; Ignee A; Hocke M; Seitz K; Schrade G; Dietrich CF
    Ultraschall Med; 2014 Jun; 35(3):246-52. PubMed ID: 23888425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic parameters of the hepatic artery and vein can detect liver metastases: assessment using contrast-enhanced ultrasound.
    Zhou JH; Li AH; Cao LH; Jiang HH; Liu LZ; Pei XQ; Han F
    Br J Radiol; 2008 Feb; 81(962):113-9. PubMed ID: 18070827
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The EFSUMB Guidelines and Recommendations on the Clinical Practice of Contrast Enhanced Ultrasound (CEUS): update 2011 on non-hepatic applications.
    Piscaglia F; Nolsøe C; Dietrich CF; Cosgrove DO; Gilja OH; Bachmann Nielsen M; Albrecht T; Barozzi L; Bertolotto M; Catalano O; Claudon M; Clevert DA; Correas JM; D'Onofrio M; Drudi FM; Eyding J; Giovannini M; Hocke M; Ignee A; Jung EM; Klauser AS; Lassau N; Leen E; Mathis G; Saftoiu A; Seidel G; Sidhu PS; ter Haar G; Timmerman D; Weskott HP
    Ultraschall Med; 2012 Feb; 33(1):33-59. PubMed ID: 21874631
    [No Abstract]   [Full Text] [Related]  

  • 12. Hepatic Vein Arrival Time for Diagnosis of Liver Cirrhosis: A 10-Year Single-Center Experience With Contrast-Enhanced Sonography.
    Abbattista T; Ridolfi F; Consalvo GT; Brunelli E
    J Ultrasound Med; 2016 Oct; 35(10):2121-8. PubMed ID: 27503751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitative contrast enhanced ultrasound of the liver for time intensity curves-Reliability and potential sources of errors.
    Ignee A; Jedrejczyk M; Schuessler G; Jakubowski W; Dietrich CF
    Eur J Radiol; 2010 Jan; 73(1):153-8. PubMed ID: 19157739
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Doppler perfusion index and contrast-enhanced ultrasound in patients with colorectal cancer liver metastases.
    Ruan L; Wang S; Zhang J; Ai H; Zhao Q; Yang J; Wei W
    Hepatogastroenterology; 2014; 61(129):37-41. PubMed ID: 24895790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Contrast-enhanced ultrasound for characterisation of focal liver lesions, practical advice].
    Fröhlich E; Jenssen C; Schuler A; Dietrich CF
    Z Gastroenterol; 2015 Sep; 53(9):1099-107. PubMed ID: 26367027
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time-intensity-based quantification of vascularity with single-level dynamic contrast-enhanced ultrasonography: a pilot animal study.
    Li J; Dong BW; Yu XL; Wang XH; Li CF
    J Ultrasound Med; 2005 Jul; 24(7):975-83. PubMed ID: 15972712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatic transit time of an echo enhancer: an indicator of metastatic spread to the liver.
    Bernatik T; Becker D; Neureiter D; Hänsler JH; Frieser M; Schaber S; Wein A; Hahn EG; Strobel D
    Eur J Gastroenterol Hepatol; 2004 Mar; 16(3):313-7. PubMed ID: 15195896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic transit time analysis using contrast enhanced MRI with Gd-BOPTA: A prospective study comparing patients with liver metastases from colorectal cancer and healthy volunteers.
    Hohmann J; Newerla C; Müller A; Reinicke C; Skrok J; Frericks BB; Albrecht T
    J Magn Reson Imaging; 2012 Dec; 36(6):1389-94. PubMed ID: 22893441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of repetitive contrast agent injections on functional and molecular ultrasound measurements.
    Rix A; Palmowski M; Gremse F; Palmowski K; Lederle W; Kiessling F; Bzyl J
    Ultrasound Med Biol; 2014 Oct; 40(10):2468-75. PubMed ID: 25023096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatic transit time of an ultrasound echo enhancer indicating the presence of liver metastases - first clinical results].
    Bernatik T; Strobel D; Häusler J; Hahn EG; Becker D
    Ultraschall Med; 2002 Apr; 23(2):91-5. PubMed ID: 11961721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.